Carboxymethylcellulose-Based and Docetaxel-Loaded Nanoparticles Circumvent P-Glycoprotein-Mediated Multidrug Resistance
- 24 February 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 11 (8), 2592-2599
- https://doi.org/10.1021/mp400643p
Abstract
Taxanes are a class of anticancer agents with a broad spectrum and have been widely used to treat a variety of cancer. However, its long-term use has been hampered by accumulating toxicity and development of drug resistance. The most extensively reported mechanism of resistance is the overexpression of P-glycoprotein (Pgp). We have developed a PEGylated carboxymethylcellulose conjugate of docetaxel (Cellax), which condenses into ∼120 nm nanoparticles. Here we demonstrated that Cellax therapy did not upregulate Pgp expression in MDA-MB-231 and EMT-6 breast tumor cells, whereas a significant increase in Pgp expression was measured with native docetaxel (DTX) treatment. Treatment with DTX led to 4–7-fold higher Pgp mRNA expression and 2-fold higher Pgp protein expression compared with Cellax treatment in the in vitro and in vivo system, respectively. Cellax also exhibited significantly increased efficacy compared with that of DTX in a taxane-resistant breast tumor model. Against the highly Pgp expressing EMT6/AR1 cells, Cellax exhibited a 6.5 times lower IC50 compared with that of native DTX, and in the in vivo model, Cellax exhibited 90% tumor growth inhibition, while native DTX had no significant antitumor activity.Keywords
This publication has 23 references indexed in Scilit:
- Multifunctional Nanoparticles Based on a Single-Molecule Modification for the Treatment of Drug-Resistant CancerMolecular Pharmaceutics, 2013
- A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastasesJournal of Controlled Release, 2012
- Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell DeathInternational Journal of Molecular Sciences, 2012
- Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian CancerMolecular Cancer Therapeutics, 2011
- The role of Tau protein in resistance to paclitaxelCancer Chemotherapy and Pharmacology, 2011
- Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in CancerMolecular Pharmaceutics, 2010
- The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumorsBMC Cancer, 2009
- Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumorsJournal of Controlled Release, 2007
- A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle SystemThe Journal of pharmacology and experimental therapeutics, 2006
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002